ZhengZHeJSongY, et al. Triglyceride-glucose index mediated by metabolic burden predicts cardiovascular events in patients with complex coronary lesions: a prospective cohort study. Angiology. Published online November 18, 2025. doi:10.1177/00033197251390139
2.
HeJYuanSSongC, et al. High triglyceride-glucose index predicts cardiovascular events in patients with coronary bifurcation lesions: a large-scale cohort study. Cardiovasc Diabetol. 2023;22(1):289.
3.
WangLCongHLZhangJX, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80.
4.
LiuYZhuBZhouW, et al. Triglyceride-glucose index as a marker of adverse cardiovascular prognosis in patients with coronary heart disease and hypertension. Cardiovasc Diabetol. 2023;22(1):133.
5.
NinomiyaKSerruysPWGargS, et al. Predicted and observed mortality at 10 years in patients with bifurcation lesions in the SYNTAX trial. JACC Cardiovasc Interv. 2022;15(12):1231-1242.
6.
YangQVijayakumarAKahnBB.Metabolites as regulators of insulin sensitivity and metabolism. Nat Rev Mol Cell Biol. 2018;19(10):654-672.
7.
MolinaMNFerderLManuchaW.Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.
8.
NishikawaTKukidomeDSonodaK, et al. Impact of mitochondrial ROS production in the pathogenesis of insulin resistance. Diabetes Res Clin Pract. 2007;77(Suppl. 1):S161-S164.
9.
GerritsAJKoekmanCAvan HaeftenTWAkkermanJW.Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes. 2010;59(6):1487-1495.
10.
HillMAYangYZhangL, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.